Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Dransfield and colleagues1 advocate the use of β blockers even in patients admitted with acute exacerbations of chronic obstructive pulmonary disease (COPD), but certain points need further discussion.
Their retrospective analysis highlights the discordance in practice that exists between cardiologist and pulmonologist. Indeed, the former is keen to commence β blockers in patients with a wide range of cardiovascular diseases …